A

Apellis Pharmaceuticals

Develops complement inhibition therapies for diseases

Hematology Account Manager - PNH

Field SalesConfirmed live in the last 24 hours
Full-timeDenver, CO, USA

About the Job

Requirements

  • A Bachelor of Arts or Bachelor of Science degree is required.
  • At least 4 years of biotech or pharmaceutical sales and account management experience is required.
  • Candidates must have a proven track record of sales success.
  • Candidates must be able to create and execute customer and account plans informed by local knowledge and aligned with headquarters strategy and tactics.
  • Candidates must demonstrate an understanding of customer and account needs and the ability to build strong relationships, credibility, and trust.
  • Candidates must demonstrate learning agility in new challenges, roles, or situations.
  • Candidates must be comfortable navigating ambiguity and persevering in an ultra-rare disease space.
  • Candidates must collaborate effectively with company stakeholders and demonstrate emotional intelligence.
  • Candidates must persevere and focus on solutions when encountering obstacles in a highly competitive market.
  • Candidates must communicate effectively, listen actively, express ideas fluently and succinctly, and present effectively.
  • Candidates must demonstrate integrity and respect for applicable rules and regulations within the pharmaceutical sector.
  • Candidates must live in the territory and be willing to travel domestically up to 75% of the time, including overnight travel, depending on the territory.
  • Candidates must be willing and able to comply fully with applicable credentialing requirements for customer interactions.

Responsibilities

  • Build and maintain proficiency in relevant disease states, patient and clinic experience, the market landscape, and the product.
  • Drive company revenue by achieving sales and marketing objectives and goals.
  • Serve as the primary commercial interface with key accounts and be accountable for the overall customer experience.
  • Develop and maintain a deep understanding of and relationships with key accounts and their relevant stakeholders, including physicians, nurses, office staff, and management.
  • Establish and execute business plans for key accounts in alignment with franchise strategy and resources; communicate those plans effectively and lead key account strategy discussions with leadership to build understanding and support.
  • Assess treatment patterns and referral networks affiliated with key accounts.
  • Collaborate compliantly with patient services, field access (reimbursement support), medical affairs, and operations teams to achieve account objectives.
  • Support fellow team members and Hematology (PNH) Account Manager colleagues when needed, and proactively share knowledge and expertise to contribute to team success.
  • Use approved resources effectively to achieve territory and account objectives.
  • Communicate routinely with the Hematology Sales Director to discuss and share ideas, challenges, and best practices.
  • Share field insights with the home-office team, including innovative engagement tactic ideas, and participate in internal workshops and insight readouts as needed.
  • Operate with professional integrity, within established guidelines and policies, and in alignment with company culture and values.

Desired Qualifications

  • Experience working in hematology/oncology and/or rare disease is preferred; specialty sales experience in other disease states will also be considered.

About the Company

Apellis Pharmaceuticals

Develops complement inhibition therapies for diseases

Apellis Pharmaceuticals develops therapies that target the complement system, a part of the immune system involved in inflammation and disease. The company focuses on complement inhibition to treat rare and debilitating conditions with unmet medical needs. Its approach centers on therapies that precisely modulate the complement cascade to help patients. Apellis went public in 2017 to fund its research and development efforts, and in 2025 it formed a strategic partnership with Sobi to sell ex-US royalties on its drug Aspaveli for up to $300 million, providing capital and expanding global reach. Compared with competitors, Apellis pursues targeted complement modulation and leverages strategic partnerships and royalties to support its growth. The company's goal is to advance effective, targeted treatments that improve the lives of patients worldwide by addressing diseases driven by the complement system.

Company size
501-1,000
Company stage
IPO
Headquarters
Waltham, MA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Apellis Pharmaceuticals

See more jobs